Research
Loading latest report…
Loading research access…
Information on this site is for informational purposes only and is not investment advice. Always do your own research and consult a licensed advisor before making financial decisions. Data timestamps use US Eastern Time unless noted.
UBS
Sep 17, 2026 · CRM
Tags: CRM Salesforce Dreamforce AIforce Agentforce AI-monetization SaaS-pricing customer-checks
Value Score: 7.5/10
Core Conclusion: UBS comes away from Dreamforce constructive on Salesforce's ability to use AIforce and Agentforce to increase CRM usage, but still Neutral on the stock. The checks suggest customers are moving ahead with AI deployments, yet the planned monetization path looks expensive, selective, and likely slower than a clean AI upsell narrative would imply.
AIforce pricing is the main friction point. UBS says the premium AIforce Max edition lists at $550 per seat/month, about a 180% premium to the $195 Core offering used by most customers. A narrower $60-75 per seat bundle exists, but UBS believes Dreamforce messaging and sales incentives were oriented toward the Max SKU. That makes adoption plausible for high-value users, but harder to scale broadly in a tight software-budget environment.
Usage monetization may lag usage growth. UBS believes Salesforce may move patiently on usage-based pricing because it does not yet have enough usage data to enforce or even fully disclose a pricing model. Customers also pay the AI model provider for tokens, so Salesforce has to avoid making AIforce feel like a double bill. The near-term implication is mixed: easier adoption, but possible gross-margin pressure if AI usage costs are not fully monetized.
UBS trimmed the FY28 revenue-growth path. Salesforce did not raise its $63bn FY30 revenue target, which already requires roughly 10.5% CAGR from FY27 guidance despite only 7% organic growth last quarter. UBS now expects the path to be more FY29/FY30 weighted and lowered FY28 total revenue growth from 10.7% to 10.0%, partly because Tableau and other license-based segments are headwinds and customers may fund AI by cutting unused seats/modules elsewhere.
Valuation is not demanding, but UBS does not see a rerating setup. Salesforce trades at about 14x CY27E FCF, 15x non-GAAP EPS, and 23x GAAP EPS. UBS raises the price target to $260 from $240, based on 14x CY27E EV/FCF, mainly due to peer multiple expansion. The rating remains Neutral because UBS does not see material rerating potential if organic revenue growth stays in the 7-9% range.
Customers are not pulling back from AI. UBS says every customer it met was
